Dr. Lori Dupree

Clinical Assistant Professor

Education

  • Pharm.D., Samford University McWhorter School of Pharmacy
  • Pharmacy Practice Residency, University of Virginia Health System
  • Internal Medicine Specialty Residency, University of Tennessee Medical Center
  • Board Certified Pharmacotherapy Specialist

Courses

  • PHA 473 Practice of Pharmacy III
  • PHA 474 Practice of Pharmacy IV
  • PHA 483 Intro Pharmacy Practice Experience III
  • PHA 517 Introductory Pharmacy Practice Experience
  • PHA 590 Comprehensive Patient Centered Care

Professional Involvement

  • American Association of Colleges of Pharmacy (AACP)
  • American College of Clinical Pharmacy (ACCP)
  • Georgia Society of Health-System Pharmacists (GSHP)

Publications

  • Moorman Li R, Dupree L, Doering, P. Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine. In: Pharmacotherapy: A Pathophysiologic Approach. (11th ed). New York, NY: McGraw Hill, 2020.
  • Thomas C, Dupree L, DeLosSantos M, et al. Evaluation of the protective effects of ß-blockers in the management of acute exacerbations of chronic obstructive pulmonary disease. J Clin Pharm Therap 2019;44:109-114.
  • Dupree L. Chapter 42: Drugs for Anemia. In: Whalen K, Finkel R, Panavelil TA, (eds). Lippincott`s Illustrated Reviews: Pharmacology. 7th Ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2018; 565-571.
  • Dupree L, DeLosSantos M, Smotherman, C. Evaluation of adherence to guideline-directed antithrombotic therapy for atrial fibrillation at hospital discharge. J Cardiovasc Pharmacol Ther 2018;23:502-508.
  • Reddy P, Dupree L. Practical approach to VTE management in hospitalized patients. Am J Ther 2017;24:e442-e467.
  • Egelund EF, Dupree L, Huesgen E, et al. The pharmacological challenges of treating tuberculosis and HIV coinfections. Expert Rev Clin Pharmacol 2017;10:213-223.
  • Hanify JM, Dupree LH, Johnson DW, et al. Failure of chemical thromboprophylaxis in critically ill medical and surgical patients with sepsis. J Crit Care 2017;37:206-210.
  • Reddy P, Dupree L. Approach to antihypertensive therapy. Am J Ther 2016;23:e451-73.
  • Estep P, Ferreira J, Dupree L, et al. Impact of an antimicrobial stewardship initiative to evaluate B-lactam allergy in patients ordered aztreonam. Am J Health-Syst Pharm 2016;73:S8-13.
  • Dupree LH. Achieving excellence in pharmaceutical care. South Med J 2015;108:627.
  • Jones KA, Dupree L. Clostridium difficile infection: a review for pharmacists. Florida Pharmacy Today 2015;78:22-24.
  • Dupree L, Reddy P. Use of rivaroxaban in patient with history of nephrotic syndrome and Ann Pharmacother 2014;48:1655-1658.
  • Gomes DM, Birch A, Smotherman C, Dupree L, Della Vecchia BJ, Kraemer DF, Jankowski CA. Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime. Pharmacotherapy 2014:34:662-669.
  • Floresca D, Dupree L, Basile S, Tan P. Evaluation of appropriate serological testing for suspected heparin-induced thrombocytopenia in hospitalized patients. Am J Health-Syst Pharm 2012;69:1581-7.

Contact Dr. Dupree


678.547.6123
dupree_lh@mercer.edu